UCM in the AFR, page-336

Today's small cap presentation with NWR was fantastic. Well my overview of this presentation for those who cannot view.

A few highlights.

- The barrier to entry for biotech stocks is high, but once overcome, the profitability is much easier - as we are seeing now.
- The increased sales in the current presentation are ONLY the banked and paid for accounts, they do not include all sales for the period.
- The presentation only covers those paid for up until the 23rd of March, so the 4C will be more extensive.
- Rob has not given a day by day account of sales, as he has seen investors asking for, because the situation is so fluid with the coronavirus.
- USCOM has been a vital part of the coronavirus response.
- The failures of modern medical systems during this pandemic will lead to a structural change in many systems, and so sales will continue to increase after the pandemic as governments improve their system.

Worth a watch if you can access it. Cheers